|
IL28RA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.040800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.68510000000599E-05 |
| Normal-vs-Stage2 |
6.225000E-01 |
| Normal-vs-Stage3 |
9.868100E-02 |
| Normal-vs-Stage4 |
1.178440E-01 |
| Stage1-vs-Stage2 |
3.548100E-02 |
| Stage1-vs-Stage3 |
2.373500E-02 |
| Stage1-vs-Stage4 |
6.989700E-02 |
| Stage2-vs-Stage3 |
5.025400E-01 |
| Stage2-vs-Stage4 |
4.994400E-01 |
| Stage3-vs-Stage4 |
9.101800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.633500E-04 |
| Normal-vs-AfricanAmerican |
3.959600E-02 |
| Normal-vs-Asian |
3.039800E-02 |
| Caucasian-vs-AfricanAmerican |
9.638200E-01 |
| Caucasian-vs-Asian |
7.021200E-01 |
| AfricanAmerican-vs-Asian |
7.542400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.315800E-02 |
| Normal-vs-Female |
4.794100E-04 |
| Male-vs-Female |
4.077600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.78601999999417E-05 |
| Normal-vs-Age(41-60Yrs) |
6.819400E-03 |
| Normal-vs-Age(61-80Yrs) |
5.970000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.859800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.449700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.551570E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.269200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.255600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.318000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.401800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.558700E-03 |
| Classical-VS-Follicular |
6.438000E-04 |
| Classical-VS-Other |
4.268200E-01 |
| Classical-VS-Normal |
4.7094999999775E-06 |
| Tall-VS-Follicular |
8.391400E-01 |
| Tall-VS-Other |
1.443380E-01 |
| Tall-VS-Normal |
5.629400E-01 |
| Follicular-VS-Other |
9.674200E-02 |
| Follicular-VS-Normal |
7.377200E-01 |
| Other-VS-Normal |
1.024770E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.342100E-02 |
| Normal-vs-N1 |
1.438150E-02 |
| N0-vs-N1 |
3.407000E-01 |
|
|
